시장보고서

상품코드

1628892

세계의 차세대당뇨병 치료 및 약물 전달 시장 : 제품 유형별, 적응증별, 인구 구조별, 최종 사용자별, 국가별, 지역별-산업 분석, 시장 규모, 점유율, 예측(2024-2032년)

Next Generation Diabetes Therapy and Drug Delivery Market, By Product Type, By Indication, By Demographic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

차세대당뇨병 치료 및 약물 전달 시장 규모는 2023년에 98억 2,032만 달러로 평가되었고, 2024년부터 2032년까지 CAGR 14.29%로 확대될 전망입니다.

차세대당뇨병 치료 및 약물 전달 시장 역학

당뇨병 유병률 증가가 시장 수요 촉진

세계의 당뇨병 유병률 상승이 혁신적인 치료법에 대한 수요를 촉진하고 있습니다. 또, 도시화, 건강에 해로운 식생활, 운동량의 감소 등이 차세대당뇨병 치료 및 약물 전달 시장의 성장에 기여하고 있습니다. 그러나 높은 비용과 규제 문제는 시장 성장을 방해할 수 있습니다. 반대로 적당한 가격으로 부작용이 적은 제품의 개발이나 진단되지 않은 당뇨병 환자가 많은 것은 시장에 큰 성장 기회를 가져오고 있습니다. 또한 지속적인 포도당 모니터링(CGM)과 인슐린 패치의 개발은 당뇨병 관리를 개선하고 치료가 더 효율적이고 침습을 줄이고 있습니다.

차세대당뇨병 치료 및 약물 전달 시장 : 주요 인사이트

우리의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 14.29%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측됩니다.

제품 유형별로 CGM 시스템은 2023년 최대 시장 점유율을 보여준 것으로 평가됩니다.

적응증별로 보면 2023년에는 2형 당뇨병이 주요 부문이 되었습니다.

인구구조학적 세분화를 바탕으로 2023년에는 성인 인구(14세 이상)가 주요 부문이었습니다.

지역별로는 북미가 2023년 매출에서 최고였습니다.

차세대당뇨병 치료제 및 약물 전달 시장 : 세분화 분석

세계의 차세대당뇨병 치료 및 약물 전달 시장은 제품 유형별, 적응증별, 인구 구조별, 최종 사용자별 및 지역별로 세분화됩니다.

시장은 제품 유형에 따라 경구 인슐린, 흡입 인슐린, CGM 시스템, 인슐린 패치, 인공 췌장의 5가지로 분류됩니다. CGM 시스템 분야가 시장을 독점하고 있습니다. 이는 사용자 친화적인 기능과 보다 빠르고 효율적으로 혈당의 변화를 검출하는 능력과 같은 기존의 당뇨병 제품에 대한 이러한 시스템의 장점 때문입니다.

시장은 적응증에 따라 두 가지 범주로 나뉩니다. 1형 당뇨병과 2형 당뇨병입니다. 2형 당뇨병 분야가 시장을 독점하고 있으며, 예측 기간 동안에도 그 우위성은 유지될 것으로 보입니다. 이 배경에는 도시화의 진전, 식생활의 혼란, 앉기 쉬운 라이프 스타일 등에 의해 2형 당뇨병의 유병률이 증가하고 있는 경우가 있습니다.

차세대당뇨병 치료 및 약물 전달 시장 : 지역별 분석

지리적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양 및 중동 및 아프리카의 각 지역으로 퍼져 있습니다. 이 지역은 비즈니스를 제공하는 국가에 의해 더 나뉩니다.

차세대당뇨병 치료 및 약물 전달 시장 : 경쟁 구도

보다 효과적이고 침습이 적은 당뇨병 관리에 대한 수요가 높아짐에 따라 기업은 경구 및 흡입 인슐린, 인슐린 패치, 지속 포도당 모니터링 시스템 등의 혁신적인 솔루션에 주력하고 있습니다. 제조업체 각 회사는 비침습적이고 사용자 친화적인 제품을 개발하기 위해 연구 개발에 대한 투자를 늘리고 있습니다. 전략적 파트너십, 하이테크 기업과의 제휴, 전문성이 높은 신흥 기업 인수는 기업이 제품 포트폴리오를 강화하고 차세대 치료의 상업화를 가속화하는 데 도움이 됩니다.

서문
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석 : 차세대당뇨병 치료 및 약물 전달 업계

경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
기업 프로파일
- MannKind Corporation
- Medtronic plc
- Dexcom, Inc.
- Novo Nordisk A/S
- Senseonics Holdings, Inc.
- Eli Lilly and Company
- Abbott laboratories
- Glysens Incorporated
- Johnson &Johnson
- Sanofi SA
- Enteris BioPharma
- Echo Therapeutics, Inc.
- Others

제13장 애널리스트의 전방위 분석

AJY 25.02.10

REPORT HIGHLIGHT

Next generation diabetes therapy and drug delivery market size was valued at USD 9,820.32 Million in 2023, expanding at a CAGR of 14.29% from 2024 to 2032.

Next-generation diabetes therapy and drug delivery aim to improve the management of blood glucose levels through advanced, less invasive methods. These include oral and inhalable insulin, insulin patches, continuous glucose monitoring (CGM) systems, and artificial pancreas technologies. By reducing the need for needles, these innovations minimize pain and skin irritation, offering patients more convenient, effective, and comfortable solutions for managing their diabetes and adjusting insulin levels based on real-time glucose data.

Next Generation Diabetes Therapy and Drug Delivery Market- Market Dynamics

Growing prevalence of diabetes to propel market demand

The rising global prevalence of diabetes is driving demand for innovative therapies. Besides, urbanization, unhealthy diets, and reduced physical activity are contributing to the growth of the next-generation diabetes therapy and drug delivery market. However, high costs and regulatory challenges may hamper the market growth. On the contrary, development of affordable, low-side-effect products and the large population of undiagnosed diabetic patients present significant growth opportunities for the market. Furthermore, developments in continuous glucose monitoring (CGM) and insulin patches are improving diabetes management, making treatments more efficient and less invasive.

Next Generation Diabetes Therapy and Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.29% over the forecast period (2024-2032)

Based on product type segmentation, CGM systems was predicted to show maximum market share in the year 2023

Based on indication segmentation, Type 2 diabetes was the leading segment in 2023

Based on demographic segmentation, adult population (>14 years) was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Next Generation Diabetes Therapy and Drug Delivery Market- Segmentation Analysis:

The Global Next Generation Diabetes Therapy and Drug Delivery Market is segmented on the basis of Product Type, Indication, Demographic, End User, and Region.

The market is divided into five categories based on product type: oral insulin, inhalable insulin, CGM systems, insulin patches, and artificial pancreas. The CGM systems sector dominates the market. This can be attributed to the benefits of these systems over traditional diabetes products, including user-friendly features and the ability to detect changes in blood glucose levels more quickly and efficiently.

The market is divided into two categories based on indication: Type 1 diabetes and Type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the prevalence of type 2 diabetes owing to by increasing urbanization, poor diets, and sedentary lifestyles.

Next Generation Diabetes Therapy and Drug Delivery Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Next Generation Diabetes Therapy and Drug Delivery Market- Competitive Landscape:

Driven by the growing demand for more effective and less invasive diabetes management, companies are focusing on innovative solutions such as oral and inhalable insulin, insulin patches, and continuous glucose monitoring systems. Manufacturers are increasingly investing in research and development to create non-invasive, user-friendly products. Strategic partnerships, collaborations with tech firms, and acquisitions of specialized startups are helping companies enhance their product portfolios and accelerate the commercialization of next-generation therapies.

Recent Developments:

In June 2024, AstraZeneca received approval for its Farxiga (dapagliflozin) for improving glycaemic control in pediatric patients aged 10 and older with type-2 diabetes. This approval follows positive results from the T2NOW Phase III trial, marking a significant development in pediatric diabetes treatment. Farxiga was previously approved for adults with type-2 diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

MannKind Corporation
Medtronic plc
Dexcom, Inc.
Novo Nordisk A/S
Senseonics Holdings, Inc.
Eli Lilly and Company
Abbott laboratories
Glysens Incorporated
Johnson & Johnson
Sanofi S.A.
Enteris BioPharma
Echo Therapeutics, Inc.
Others

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Oral Insulin
Inhalable Insulin
CGM Systems
Insulin Patches
Artificial Pancreas

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Type 1 Diabetes
Type 2 Diabetes

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY DEMOGRAPHIC- MARKET ANALYSIS, 2019 - 2032

Child Population (14 years)
Adult Population (<14 years)

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Home Healthcare
ICUs
Diagnostic/Clinics

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Next Generation Diabetes Therapy and Drug Delivery Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Product Type
- 2.1.2. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Indication
- 2.1.3. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Demographic
- 2.1.4. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by End User
- 2.1.5. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Country
- 2.1.6. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Region
2.2. Competitive Insights

3. Next Generation Diabetes and Drug Delivery Key Market Trends

3.1. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Next Generation Diabetes Therapy and Drug Delivery Market Opportunities
3.4. Next Generation Diabetes Therapy and Drug Delivery Market Future Trends

4. Next Generation Diabetes and Drug Delivery Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Next Generation Diabetes Therapy and Drug Delivery Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Next Generation Diabetes Therapy and Drug Delivery Market Landscape

6.1. Next Generation Diabetes Therapy and Drug Delivery Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Next Generation Diabetes Therapy and Drug Delivery Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. Oral Insulin
- 7.1.3. Inhalable Insulin
- 7.1.4. CGM Systems
- 7.1.5. Insulin Patches
- 7.1.6. Artificial Pancreas

8. Next Generation Diabetes Therapy and Drug Delivery Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 8.1.2. Type 1 Diabetes
- 8.1.3. Type 2 Diabetes

9. Next Generation Diabetes Therapy and Drug Delivery Market - By Demographic

9.1. Overview
- 9.1.1. Segment Share Analysis, By Demographic, 2023 & 2032 (%)
- 9.1.2. Child Population (14 years)
- 9.1.3. Adult Population (>14 years)

10. Next Generation Diabetes Therapy and Drug Delivery Market - By End User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 10.1.2. Home Healthcare
- 10.1.3. ICUs
- 10.1.4. Diagnostic/Clinics

11. Next Generation Diabetes Therapy and Drug Delivery Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Next Generation Diabetes and Drug Delivery Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. MannKind Corporation
- 12.2.2. Medtronic plc
- 12.2.3. Dexcom, Inc.
- 12.2.4. Novo Nordisk A/S
- 12.2.5. Senseonics Holdings, Inc.
- 12.2.6. Eli Lilly and Company
- 12.2.7. Abbott laboratories
- 12.2.8. Glysens Incorporated
- 12.2.9. Johnson & Johnson
- 12.2.10. Sanofi S.A.
- 12.2.11. Enteris BioPharma
- 12.2.12. Echo Therapeutics, Inc.
- 12.2.13. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us